Mural Oncology PLC (MURA)
3.71
+0.06
(+1.64%)
USD |
NASDAQ |
Jan 10, 10:22
Mural Oncology Enterprise Value: -113.23M for Jan. 8, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Amarin Corp PLC | -78.14M |
| Jazz Pharmaceuticals PLC | 10.76B |
| Prothena Corp PLC | 242.67M |
| Iterum Therapeutics PLC | 37.73M |
| GH Research PLC | 317.18M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -31.76M |
| Total Expenses (Quarterly) | 34.10M |
| EPS Diluted (Quarterly) | -1.87 |
| Earnings Yield | -246.3% |